位置:首页 > 蛋白库 > TEN3_MOUSE
TEN3_MOUSE
ID   TEN3_MOUSE              Reviewed;        2715 AA.
AC   Q9WTS6; A0A2K9QKY6; A0A2K9QKZ0; A0A2K9QL01; A0A2K9QL03; A0A2K9QL04;
AC   A0A2K9QL11; A0A2K9QL36; A0A2K9QL87; Q3UVR9; Q3UX72; Q80TD2; Q8BSL5; Q9CSV2;
AC   Q9JLC1;
DT   31-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   23-FEB-2022, entry version 134.
DE   RecName: Full=Teneurin-3 {ECO:0000303|PubMed:29414938};
DE            Short=Ten-3 {ECO:0000303|PubMed:29414938};
DE   AltName: Full=Protein Odd Oz/ten-m homolog 3 {ECO:0000303|PubMed:10225957, ECO:0000303|PubMed:10625539};
DE   AltName: Full=Tenascin-M3 {ECO:0000303|PubMed:23028443};
DE            Short=Ten-m3 {ECO:0000303|PubMed:23028443};
DE   AltName: Full=Teneurin transmembrane protein 3 {ECO:0000303|PubMed:23028443};
GN   Name=Tenm3 {ECO:0000312|MGI:MGI:1345183};
GN   Synonyms=Kiaa1455 {ECO:0000303|PubMed:12693553},
GN   Odz3 {ECO:0000303|PubMed:10225957, ECO:0000303|PubMed:10625539},
GN   Tnm3 {ECO:0000303|PubMed:23028443};
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A1B1), AND DOMAIN.
RC   STRAIN=BALB/cJ; TISSUE=Brain;
RX   PubMed=10225957; DOI=10.1083/jcb.145.3.563;
RA   Oohashi T., Zhou X.-H., Feng K., Richter B., Moergelin M., Perez M.T.,
RA   Su W.D., Chiquet-Ehrismann R., Rauch U., Faessler R.;
RT   "Mouse ten-m/Odz is a new family of dimeric type II transmembrane proteins
RT   expressed in many tissues.";
RL   J. Cell Biol. 145:563-577(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 354-2715 (ISOFORM A0B0).
RX   PubMed=10625539; DOI=10.1006/dbio.1999.9532;
RA   Ben-Zur T., Feige E., Motro B., Wides R.;
RT   "The mammalian Odz gene family: homologs of a Drosophila pair-rule gene
RT   with expression implying distinct yet overlapping developmental roles.";
RL   Dev. Biol. 217:107-120(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 707-1248 (A0B0; A0B1; A1B0; A1B1; A2B0; A2B1;
RP   A3B0 AND A3B1), FUNCTION, SUBCELLULAR LOCATION, SUBUNIT, TISSUE
RP   SPECIFICITY, AND DISRUPTION PHENOTYPE.
RX   PubMed=29414938; DOI=10.1038/nature25463;
RA   Berns D.S., DeNardo L.A., Pederick D.T., Luo L.;
RT   "Teneurin-3 controls topographic circuit assembly in the hippocampus.";
RL   Nature 554:328-333(2018).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 871-2715 (ISOFORM A0B0), AND
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1640-2715 (ISOFORM A1B1).
RC   STRAIN=C57BL/6J; TISSUE=Egg, Embryo, and Forelimb;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 888-2715 (ISOFORM A1B1).
RC   TISSUE=Brain;
RX   PubMed=12693553; DOI=10.1093/dnares/10.1.35;
RA   Okazaki N., Kikuno R., Ohara R., Inamoto S., Aizawa H., Yuasa S.,
RA   Nakajima D., Nagase T., Ohara O., Koga H.;
RT   "Prediction of the coding sequences of mouse homologues of KIAA gene: II.
RT   The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs
RT   identified by screening of terminal sequences of cDNA clones randomly
RT   sampled from size-fractionated libraries.";
RL   DNA Res. 10:35-48(2003).
RN   [6]
RP   HOMODIMERIZATION, AND HETERODIMERIZATION.
RX   PubMed=12000766; DOI=10.1074/jbc.m203722200;
RA   Feng K., Zhou X.H., Oohashi T., Morgelin M., Lustig A., Hirakawa S.,
RA   Ninomiya Y., Engel J., Rauch U., Fassler R.;
RT   "All four members of the Ten-m/Odz family of transmembrane proteins form
RT   dimers.";
RL   J. Biol. Chem. 277:26128-26135(2002).
RN   [7]
RP   TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=12915301; DOI=10.1016/s1567-133x(03)00087-5;
RA   Zhou X.H., Brandau O., Feng K., Oohashi T., Ninomiya Y., Rauch U.,
RA   Fassler R.;
RT   "The murine Ten-m/Odz genes show distinct but overlapping expression
RT   patterns during development and in adult brain.";
RL   Gene Expr. Patterns 3:397-405(2003).
RN   [8]
RP   FUNCTION IN AXON GUIDANCE, DISRUPTION PHENOTYPE, TISSUE SPECIFICITY, AND
RP   DEVELOPMENTAL STAGE.
RX   PubMed=17803360; DOI=10.1371/journal.pbio.0050241;
RA   Leamey C.A., Merlin S., Lattouf P., Sawatari A., Zhou X., Demel N.,
RA   Glendining K.A., Oohashi T., Sur M., Fassler R.;
RT   "Ten_m3 regulates eye-specific patterning in the mammalian visual pathway
RT   and is required for binocular vision.";
RL   PLoS Biol. 5:E241-E241(2007).
RN   [9]
RP   FUNCTION IN CELL ADHESION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=17478416; DOI=10.1093/cercor/bhm031;
RA   Leamey C.A., Glendining K.A., Kreiman G., Kang N.D., Wang K.H., Fassler R.,
RA   Sawatari A., Tonegawa S., Sur M.;
RT   "Differential gene expression between sensory neocortical areas: potential
RT   roles for Ten_m3 and Bcl6 in patterning visual and somatosensory
RT   pathways.";
RL   Cereb. Cortex 18:53-66(2008).
RN   [10]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-380 AND ASN-2140.
RC   TISSUE=Myoblast;
RX   PubMed=19656770; DOI=10.1074/mcp.m900195-mcp200;
RA   Gundry R.L., Raginski K., Tarasova Y., Tchernyshyov I., Bausch-Fluck D.,
RA   Elliott S.T., Boheler K.R., Van Eyk J.E., Wollscheid B.;
RT   "The mouse C2C12 myoblast cell surface N-linked glycoproteome:
RT   identification, glycosite occupancy, and membrane orientation.";
RL   Mol. Cell. Proteomics 8:2555-2569(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [12]
RP   FUNCTION IN CELL DIFFERENTIATION, AND TISSUE SPECIFICITY.
RX   PubMed=20636325; DOI=10.1111/j.1469-7580.2010.01267.x;
RA   Murakami T., Fukunaga T., Takeshita N., Hiratsuka K., Abiko Y.,
RA   Yamashiro T., Takano-Yamamoto T.;
RT   "Expression of Ten-m/Odz3 in the fibrous layer of mandibular condylar
RT   cartilage during postnatal growth in mice.";
RL   J. Anat. 217:236-244(2010).
RN   [13]
RP   FUNCTION IN AXON GUIDANCE, DISRUPTION PHENOTYPE, TISSUE SPECIFICITY, AND
RP   DEVELOPMENTAL STAGE.
RX   PubMed=23028443; DOI=10.1371/journal.pone.0043083;
RA   Dharmaratne N., Glendining K.A., Young T.R., Tran H., Sawatari A.,
RA   Leamey C.A.;
RT   "Ten-m3 is required for the development of topography in the ipsilateral
RT   retinocollicular pathway.";
RL   PLoS ONE 7:E43083-E43083(2012).
RN   [14]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=22499796; DOI=10.1093/cercor/bhs030;
RA   Merlin S., Horng S., Marotte L.R., Sur M., Sawatari A., Leamey C.A.;
RT   "Deletion of Ten-m3 induces the formation of eye dominance domains in mouse
RT   visual cortex.";
RL   Cereb. Cortex 23:763-774(2013).
RN   [15]
RP   FUNCTION.
RX   PubMed=25406022; DOI=10.1111/ejn.12767;
RA   Tran H., Sawatari A., Leamey C.A.;
RT   "The glycoprotein Ten-m3 mediates topography and patterning of
RT   thalamostriatal projections from the parafascicular nucleus in mice.";
RL   Eur. J. Neurosci. 41:55-68(2015).
CC   -!- FUNCTION: Involved in neural development by regulating the
CC       establishment of proper connectivity within the nervous system
CC       (PubMed:17478416, PubMed:17803360, PubMed:23028443, PubMed:25406022,
CC       PubMed:22499796, PubMed:29414938). Acts in both pre- and postsynaptic
CC       neurons in the hippocampus to control the assembly of a precise
CC       topographic projection: required in both CA1 and subicular neurons for
CC       the precise targeting of proximal CA1 axons to distal subiculum,
CC       probably by promoting homophilic cell adhesion (PubMed:29414938).
CC       Promotes homophilic adhesion in a splicing isoform-dependent manner:
CC       most isoforms (isoform-type A and type-B) can mediate homophilic
CC       interaction (PubMed:29414938). Promotes axon guidance
CC       (PubMed:23028443). Required for proper dendrite morphogenesis and axon
CC       targeting in the vertebrate visual system, thereby playing a key role
CC       in the development of the visual pathway (PubMed:17803360,
CC       PubMed:23028443, PubMed:25406022, PubMed:22499796). Regulates the
CC       formation in ipsilateral retinal mapping to both the dorsal lateral
CC       geniculate nucleus (dLGN) and the superior colliculus (SC)
CC       (PubMed:17803360, PubMed:23028443). May also be involved in the
CC       differentiation of the fibroblast-like cells in the superficial layer
CC       of mandibular condylar cartilage into chondrocytes (PubMed:20636325).
CC       {ECO:0000269|PubMed:17478416, ECO:0000269|PubMed:17803360,
CC       ECO:0000269|PubMed:20636325, ECO:0000269|PubMed:22499796,
CC       ECO:0000269|PubMed:23028443, ECO:0000269|PubMed:25406022,
CC       ECO:0000269|PubMed:29414938}.
CC   -!- SUBUNIT: Homodimer; disulfide-linked; to mediate homophilic cell
CC       adhesion (PubMed:29414938, PubMed:12000766). Most isoforms (isoform-
CC       type A and type-B) can mediate homophilic interaction
CC       (PubMed:29414938). Heterodimer with either TENM1 or TENM2
CC       (PubMed:12000766). May also form heterodimer with TENM4
CC       (PubMed:12000766). Isoform A0B0: Does not form homodimer to mediate
CC       homophilic cell adhesion. Isoform A0B0: Heterodimer with ADGRL3
CC       (PubMed:29414938). {ECO:0000269|PubMed:12000766,
CC       ECO:0000269|PubMed:29414938}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:29414938,
CC       ECO:0000305|PubMed:17478416}; Single-pass membrane protein
CC       {ECO:0000269|PubMed:17478416}. Cell projection, axon
CC       {ECO:0000269|PubMed:17478416}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=8;
CC         Comment=8 different isoforms are produced by the inclusion or
CC         exclusion of 'exon 12' and 'exon 20' (at splice sites A and B,
CC         respectively). The different isoforms probably mediate a combination
CC         of specific homophilic and/or heterophilic interactions.
CC         {ECO:0000269|PubMed:29414938};
CC       Name=A1B1 {ECO:0000303|PubMed:29414938};
CC         IsoId=Q9WTS6-1; Sequence=Displayed;
CC       Name=A0B0 {ECO:0000303|PubMed:29414938};
CC         IsoId=Q9WTS6-2; Sequence=VSP_021402, VSP_021403;
CC       Name=A0B1 {ECO:0000303|PubMed:29414938};
CC         IsoId=Q9WTS6-3; Sequence=VSP_021402;
CC       Name=A1B0 {ECO:0000303|PubMed:29414938};
CC         IsoId=Q9WTS6-4; Sequence=VSP_059562;
CC       Name=A2B1 {ECO:0000303|PubMed:29414938};
CC         IsoId=Q9WTS6-5; Sequence=VSP_059560;
CC       Name=A2B0 {ECO:0000303|PubMed:29414938};
CC         IsoId=Q9WTS6-6; Sequence=VSP_059560, VSP_059562;
CC       Name=A3B1 {ECO:0000303|PubMed:29414938};
CC         IsoId=Q9WTS6-7; Sequence=VSP_059561;
CC       Name=A3B0 {ECO:0000303|PubMed:29414938};
CC         IsoId=Q9WTS6-8; Sequence=VSP_059561, VSP_059562;
CC   -!- TISSUE SPECIFICITY: In brain, expressed in highly specific regions of
CC       the postnatal brain: expressed in restricted domains of the developing
CC       hippocampal region, including proximal CA1, distal subiculum, and
CC       medial entorhinal cortex (at protein level) (PubMed:29414938).
CC       Expression matches with topographic connectivity between entorhinal
CC       cortex, CA1, and subiculum (at protein level) (PubMed:29414938). Also
CC       specifically expressed in subregions of the presubiculum,
CC       parasubiculum, medial mammillary nucleus and anteroventral thalamic
CC       nucleus that are topographically connected with subiculum or entorhinal
CC       cortex (at protein level) (PubMed:29414938). Expressed in neurons of
CC       the developing visual pathway (at protein level). Expressed in the
CC       dorsal and ventral lateral geniculate nucleus (dLGN and vLGN) and optic
CC       tract at birth. Expressed in ipsilateral retinal axons of terminal
CC       zones (TZs) in the developing superior colliculus (SC) throughout the
CC       first postnatal week. Expressed in the layer V of the visual caudal
CC       cortex. Expressed in the femoral and mandibular condylar cartilages.
CC       Strongly expressed in fibrous and proliferating chondrocytes. Poorly
CC       expressed in mature chondrocytes. Not expressed in hypertrophic
CC       chondrocytes (PubMed:12915301, PubMed:17478416, PubMed:17803360,
CC       PubMed:20636325, PubMed:23028443). {ECO:0000269|PubMed:12915301,
CC       ECO:0000269|PubMed:17478416, ECO:0000269|PubMed:17803360,
CC       ECO:0000269|PubMed:20636325, ECO:0000269|PubMed:23028443,
CC       ECO:0000269|PubMed:29414938}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in the neural plate at 7.5 dpc.
CC       Expressed in the forebrain and telencephalon at 8.5 dpc. Expressed in
CC       the diencephalon, spinal cord and midbrain at 12.5 dpc. Expressed in
CC       the retinal ganglion cell (RGC) layer and the dorsal lateral geniculate
CC       nucleus (dLGN) at 16 dpc. Expressed in ipsilateral retinal axons of
CC       terminal zones (TZs) in the developing superior colliculus (SC) at 16
CC       dpc, onward. {ECO:0000269|PubMed:12915301, ECO:0000269|PubMed:17803360,
CC       ECO:0000269|PubMed:23028443}.
CC   -!- DOMAIN: EGF-like domains 2 and 5 which have an odd number of cysteines
CC       might enable the formation of intermolecular disulfide bonds.
CC       {ECO:0000305|PubMed:10225957}.
CC   -!- DOMAIN: Cytoplasmic proline-rich regions could serve as docking domains
CC       for intracellular SH3-containing proteins.
CC       {ECO:0000305|PubMed:10225957}.
CC   -!- DISRUPTION PHENOTYPE: Mice show impair binocular vision, consistent
CC       with altered ipsilateral retinal neuron projections both into the
CC       ventrolateral region of the lateral geniculate nucleus (dLGN) and the
CC       superior colliculus (SC) (PubMed:17803360, PubMed:23028443). The
CC       distribution of ipsilateral drive in V1 is altered, leading to an
CC       expanded but visuotopically misaligned binocular zone
CC       (PubMed:22499796). Conditional knockout mice lacking Tenm3 in CA1
CC       neurons display proximal CA1 axons spread throughout the entire
CC       subiculum, instead of projecting only to distal regions
CC       (PubMed:29414938). When Tenm3 is absent from a subset of distal
CC       subicular cells, Tenm3-containing proximal CA1 axons do not target
CC       Tenm3 and instead innervate nearby Tenm3 regions (PubMed:29414938).
CC       {ECO:0000269|PubMed:17803360, ECO:0000269|PubMed:22499796,
CC       ECO:0000269|PubMed:23028443, ECO:0000269|PubMed:29414938}.
CC   -!- SIMILARITY: Belongs to the tenascin family. Teneurin subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAE22691.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB025412; BAA77398.1; -; mRNA.
DR   EMBL; AF195418; AAF28316.1; -; mRNA.
DR   EMBL; MG387139; AUQ44320.1; -; mRNA.
DR   EMBL; MG387140; AUQ44321.1; -; mRNA.
DR   EMBL; MG387141; AUQ44322.1; -; mRNA.
DR   EMBL; MG387142; AUQ44323.1; -; mRNA.
DR   EMBL; MG387143; AUQ44324.1; -; mRNA.
DR   EMBL; MG387144; AUQ44325.1; -; mRNA.
DR   EMBL; MG387145; AUQ44326.1; -; mRNA.
DR   EMBL; MG387146; AUQ44327.1; -; mRNA.
DR   EMBL; AK011924; BAB27919.1; -; mRNA.
DR   EMBL; AK031268; BAC27329.1; -; mRNA.
DR   EMBL; AK122513; BAC65795.1; -; mRNA.
DR   EMBL; AK135844; BAE22691.1; ALT_INIT; mRNA.
DR   EMBL; AK136994; BAE23200.1; -; mRNA.
DR   CCDS; CCDS22303.1; -. [Q9WTS6-1]
DR   CCDS; CCDS85538.1; -. [Q9WTS6-2]
DR   PDB; 6FAY; EM; 3.80 A; A=845-2715.
DR   PDBsum; 6FAY; -.
DR   SMR; Q9WTS6; -.
DR   IntAct; Q9WTS6; 1.
DR   STRING; 10090.ENSMUSP00000140141; -.
DR   GlyConnect; 2431; 3 N-Linked glycans (2 sites). [Q9WTS6-2]
DR   GlyConnect; 2757; 4 N-Linked glycans (2 sites).
DR   GlyGen; Q9WTS6; 17 sites, 4 N-linked glycans (2 sites).
DR   iPTMnet; Q9WTS6; -.
DR   PhosphoSitePlus; Q9WTS6; -.
DR   MaxQB; Q9WTS6; -.
DR   PaxDb; Q9WTS6; -.
DR   PRIDE; Q9WTS6; -.
DR   ProteomicsDB; 258991; -. [Q9WTS6-1]
DR   ProteomicsDB; 258992; -. [Q9WTS6-2]
DR   MGI; MGI:1345183; Tenm3.
DR   eggNOG; KOG4659; Eukaryota.
DR   InParanoid; Q9WTS6; -.
DR   PhylomeDB; Q9WTS6; -.
DR   ChiTaRS; Tenm3; mouse.
DR   PRO; PR:Q9WTS6; -.
DR   Proteomes; UP000000589; Unplaced.
DR   RNAct; Q9WTS6; protein.
DR   GO; GO:0030424; C:axon; IEA:UniProtKB-SubCell.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0043005; C:neuron projection; IBA:GO_Central.
DR   GO; GO:0050839; F:cell adhesion molecule binding; IBA:GO_Central.
DR   GO; GO:0042802; F:identical protein binding; IPI:MGI.
DR   GO; GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0048593; P:camera-type eye morphogenesis; ISO:MGI.
DR   GO; GO:0007157; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; IBA:GO_Central.
DR   GO; GO:0007156; P:homophilic cell adhesion via plasma membrane adhesion molecules; IDA:UniProtKB.
DR   GO; GO:0048666; P:neuron development; IBA:GO_Central.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; IDA:UniProtKB.
DR   GO; GO:1903385; P:regulation of homophilic cell adhesion; IDA:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; IEA:InterPro.
DR   Gene3D; 2.120.10.30; -; 2.
DR   InterPro; IPR011042; 6-blade_b-propeller_TolB-like.
DR   InterPro; IPR008969; CarboxyPept-like_regulatory.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR022385; Rhs_assc_core.
DR   InterPro; IPR027691; Ten-3/4.
DR   InterPro; IPR009471; Ten_N.
DR   InterPro; IPR028916; Tox-GHH_dom.
DR   InterPro; IPR006530; YD.
DR   PANTHER; PTHR11219:SF65; PTHR11219:SF65; 1.
DR   Pfam; PF06484; Ten_N; 2.
DR   Pfam; PF15636; Tox-GHH; 1.
DR   SMART; SM00181; EGF; 8.
DR   SUPFAM; SSF49464; SSF49464; 1.
DR   TIGRFAMs; TIGR03696; Rhs_assc_core; 1.
DR   TIGRFAMs; TIGR01643; YD_repeat_2x; 2.
DR   PROSITE; PS00022; EGF_1; 8.
DR   PROSITE; PS01186; EGF_2; 7.
DR   PROSITE; PS50026; EGF_3; 5.
DR   PROSITE; PS51361; TENEURIN_N; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell adhesion; Cell membrane;
KW   Cell projection; Differentiation; Disulfide bond; EGF-like domain;
KW   Glycoprotein; Membrane; Reference proteome; Repeat; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..2715
FT                   /note="Teneurin-3"
FT                   /id="PRO_0000259506"
FT   TOPO_DOM        1..310
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        311..331
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        332..2715
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          1..309
FT                   /note="Teneurin N-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00694"
FT   DOMAIN          514..545
FT                   /note="EGF-like 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          546..576
FT                   /note="EGF-like 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          578..610
FT                   /note="EGF-like 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          611..642
FT                   /note="EGF-like 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          644..677
FT                   /note="EGF-like 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          678..709
FT                   /note="EGF-like 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          710..739
FT                   /note="EGF-like 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          740..783
FT                   /note="EGF-like 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   REPEAT          1181..1209
FT                   /note="NHL 1"
FT   REPEAT          1216..1260
FT                   /note="NHL 2"
FT   REPEAT          1286..1330
FT                   /note="NHL 3"
FT   REPEAT          1347..1387
FT                   /note="NHL 4"
FT   REPEAT          1418..1445
FT                   /note="NHL 5"
FT   REPEAT          1474..1517
FT                   /note="NHL 6"
FT   REPEAT          1527..1546
FT                   /note="YD 1"
FT   REPEAT          1563..1583
FT                   /note="YD 2"
FT   REPEAT          1626..1645
FT                   /note="YD 3"
FT   REPEAT          1646..1668
FT                   /note="YD 4"
FT   REPEAT          1839..1858
FT                   /note="YD 5"
FT   REPEAT          1880..1898
FT                   /note="YD 6"
FT   REPEAT          1899..1919
FT                   /note="YD 7"
FT   REPEAT          1926..1943
FT                   /note="YD 8"
FT   REPEAT          1944..1965
FT                   /note="YD 9"
FT   REPEAT          1966..1983
FT                   /note="YD 10"
FT   REPEAT          1986..2006
FT                   /note="YD 11"
FT   REPEAT          2009..2029
FT                   /note="YD 12"
FT   REPEAT          2037..2056
FT                   /note="YD 13"
FT   REPEAT          2062..2079
FT                   /note="YD 14"
FT   REPEAT          2080..2106
FT                   /note="YD 15"
FT   REPEAT          2108..2121
FT                   /note="YD 16"
FT   REPEAT          2122..2145
FT                   /note="YD 17"
FT   REPEAT          2148..2168
FT                   /note="YD 18"
FT   REPEAT          2169..2189
FT                   /note="YD 19"
FT   REPEAT          2191..2211
FT                   /note="YD 20"
FT   REPEAT          2223..2243
FT                   /note="YD 21"
FT   REPEAT          2245..2265
FT                   /note="YD 22"
FT   REPEAT          2291..2332
FT                   /note="YD 23"
FT   REGION          1..38
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          142..223
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1..28
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        142..159
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        194..216
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CARBOHYD        345
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        380
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19656770"
FT   CARBOHYD        419
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        670
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        869
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        892
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1211
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1543
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1560
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1656
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1693
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1751
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1836
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1937
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        2140
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19656770"
FT   CARBOHYD        2280
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        2592
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        518..528
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        522..533
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        535..544
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        553..564
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        566..575
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        582..593
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        587..598
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        600..609
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        614..625
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        619..630
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        632..641
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        652..665
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        667..676
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        681..691
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        685..696
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        698..707
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        712..722
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        716..727
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        729..738
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        752..762
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        756..771
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        773..782
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   VAR_SEQ         741..749
FT                   /note="Missing (in isoform A0B0 and isoform A0B1)"
FT                   /evidence="ECO:0000269|PubMed:29414938,
FT                   ECO:0000303|PubMed:10625539, ECO:0000303|PubMed:16141072"
FT                   /id="VSP_021402"
FT   VAR_SEQ         749
FT                   /note="K -> KDKIGYK (in isoform A2B1 and isoform A2B0)"
FT                   /evidence="ECO:0000269|PubMed:29414938"
FT                   /id="VSP_059560"
FT   VAR_SEQ         749
FT                   /note="K -> KADKIGYK (in isoform A3B1 and isoform A3B0)"
FT                   /evidence="ECO:0000269|PubMed:29414938"
FT                   /id="VSP_059561"
FT   VAR_SEQ         1219..1226
FT                   /note="RNKDFRHS -> S (in isoform A1B0, isoform A2B0 and
FT                   isoform A3B0)"
FT                   /evidence="ECO:0000269|PubMed:29414938"
FT                   /id="VSP_059562"
FT   VAR_SEQ         1219..1225
FT                   /note="Missing (in isoform A0B0)"
FT                   /evidence="ECO:0000303|PubMed:10625539,
FT                   ECO:0000303|PubMed:16141072"
FT                   /id="VSP_021403"
FT   CONFLICT        1632..1637
FT                   /note="LLATKS -> AFSHQK (in Ref. 4; BAE22691)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1640
FT                   /note="T -> S (in Ref. 4; BAE23200)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2332
FT                   /note="T -> I (in Ref. 2; AAF28316 and 4; BAE23200/
FT                   BAC65795)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2482
FT                   /note="Missing (in Ref. 4; BAC27329)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2636
FT                   /note="I -> L (in Ref. 4; BAB27919)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   2715 AA;  303066 MW;  598F46A77334C2E1 CRC64;
     MDVKERRPYC SLTKSRREKE RRYTNSSADN EECRVPTQKS YSSSETLKAF DHDYSRLLYG
     NRVKDLVHRE ADEYTRQGQN FTLRQLGVCE SATRRGVAFC AEMGLPHRGY SISAGSDADT
     ENEAVMSPEH AMRLWGRGVK SGRSSCLSSR SNSALTLTDT EHENRSDSES EQPSNNPGQP
     TLQPLPPSHK QHPAQHHPSI TSLNRNSLTN RRNQSPAPPA ALPAELQTTP ESVQLQDSWV
     LGSNVPLESR HFLFKTGTGT TPLFSTATPG YTMASGSVYS PPTRPLPRNT LSRSAFKFKK
     SSKYCSWRCT ALCAVGVSVL LAILLSYFIA MHLFGLNWHL QQTENDTFEN GKVNSDTVPT
     NTVSLPSGDN GKLGGFTHEN NTIDSGELDI GRRAIQEVPP GIFWRSQLFI DQPQFLKFNI
     SLQKDALIGV YGRKGLPPSH TQYDFVELLD GSRLIAREQR NLVESERAGR QARSVSLHEA
     GFIQYLDSGI WHLAFYNDGK NPEQVSFNTI VIESVVECPR NCHGNGECVS GTCHCFPGFL
     GPDCSRAACP VLCSGNGQYS KGRCLCFSGW KGTECDVPTT QCIDPQCGGR GICIMGSCAC
     NSGYKGENCE EADCLDPGCS NHGVCIHGEC HCNPGWGGSN CEILKTMCAD QCSGHGTYLQ
     ESGSCTCDPN WTGPDCSNEI CSVDCGSHGV CMGGSCRCEE GWTGPACNQR ACHPRCAEHG
     TCKDGKCECS QGWNGEHCTI AHYLDKIVKE GCPGLCNSNG RCTLDQNGWH CVCQPGWRGA
     GCDVAMETLC TDSKDNEGDG LIDCMDPDCC LQSSCQNQPY CRGLPDPQDI ISQSLQTPSQ
     QAAKSFYDRI SFLIGSDSTH VLPGESPFNK SLASVIRGQV LTADGTPLIG VNVSFLHYSE
     YGYTITRQDG MFDLVANGGA SLTLVFERSP FLTQYHTVWI PWNVFYVMDT LVMKKEENDI
     PSCDLSGFVR PSPIIVSSPL STFFRSSPED SPIIPETQVL HEETTIPGTD LKLSYLSSRA
     AGYKSVLKIT MTQAVIPFNL MKVHLMVAVV GRLFQKWFPA SPNLAYTFIW DKTDAYNQKV
     YGLSEAVVSV GYEYESCLDL TLWEKRTAVL QGYELDASNM GGWTLDKHHV LDVQNGILYK
     GNGENQFISQ QPPVVSSIMG NGRRRSISCP SCNGQADGNK LLAPVALACG IDGSLYVGDF
     NYVRRIFPSG NVTSVLELRN KDFRHSSNPA HRYYLATDPV TGDLYVSDTN TRRIYRPKSL
     TGAKDLTKNA EVVAGTGEQC LPFDEARCGD GGKAVEATLM SPKGMAIDKN GLIYFVDGTM
     IRKVDQNGII STLLGSNDLT SARPLTCDTS MHISQVRLEW PTDLAINPMD NSIYVLDNNV
     VLQITENRQV RIAAGRPMHC QVPGVEYPVG KHAVQTTLES ATAIAVSYSG VLYITETDEK
     KINRIRQVTT DGEISLVAGI PSECDCKNDA NCDCYQSGDG YAKDAKLNAP SSLAASPDGT
     LYIADLGNIR IRAVSKNKPL LNSMNFYEVA SPTDQELYIF DINGTHQYTV SLVTGDYLYN
     FSYSNDNDVT AVTDSNGNTL RIRRDPNRMP VRVVSPDNQV IWLTIGTNGC LKSMTAQGLE
     LVLFTYHGNS GLLATKSDET GWTTFFDYDS EGRLTNVTFP TGVVTNLHGD MDKAITVDIE
     SSSREEDVSI TSNLSSIDSF YTMVQDQLRN SYQIGYDGSL RIFYASGLDS HYQTEPHVLA
     GTANPTVAKR NMTLPGENGQ NLVEWRFRKE QAQGKVNVFG RKLRVNGRNL LSVDFDRTTK
     TEKIYDDHRK FLLRIAYDTS GHPTLWLPSS KLMAVNVTYS STGQIASIQR GTTSEKVDYD
     SQGRIVSRVF ADGKTWSYTY LEKSMVLLLH SQRQYIFEYD MWDRLSAITM PSVARHTMQT
     IRSIGYYRNI YNPPESNASI ITDYNEEGLL LQTAFLGTSR RVLFKYRRQT RLSEILYDST
     RVSFTYDETA GVLKTVNLQS DGFICTIRYR QIGPLIDRQI FRFSEDGMVN ARFDYSYDNS
     FRVTSMQGVI NETPLPIDLY QFDDISGKVE QFGKFGVIYY DINQIISTAV MTYTKHFDAH
     GRIKEIQYEI FRSLMYWITI QYDNMGRVTK REIKIGPFAN TTKYAYEYDV DGQLQTVYLN
     EKIMWRYNYD LNGNLHLLNP SSSARLTPLR YDLRDRITRL GDVQYRLDED GFLRQRGTEI
     FEYSSKGLLT RVYSKGSGWT VIYRYDGLGR RVSSKTSLGQ HLQFFYADLT YPTRITHVYN
     HSSSEITSLY YDLQGHLFAM EISSGDEFYI ASDNTGTPLA VFSSNGLMLK QTQYTAYGEI
     YFDSNVDFQL VIGFHGGLYD PLTKLIHFGE RDYDILAGRW TTPDIEIWKR IGKDPAPFNL
     YMFRNNNPAS KIHDVKDYIT DVNSWLVTFG FHLHNAIPGF PVPKFDLTEP SYELVKSQQW
     EDVPPIFGVQ QQVARQAKAF LSLGKMAEVQ VSRRKAGAEQ SWLWFATVKS LIGKGVMLAV
     SQGRVQTNVL NIANEDCIKV AAVLNNAFYL ENLHFTIEGK DTHYFIKTTT PESDLGTLRL
     TSGRKALENG INVTVSQSTT VVNGRTRRFA DVEMQFGALA LHVRYGMTLD EEKARILEQA
     RQRALARAWA REQQRVRDGE EGARLWTEGE KRQLLSAGKV QGYDGYYVLS VEQYPELADS
     ANNIQFLRQS EIGKR
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024